Stage II Laryngeal Cancer AJCC v8

specific

Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Supraglottis: Tumor is limited to larynx with vocal cord fixation and/or invades any of the following: postcricoid area, preepiglottic space, paraglottic space, and/or inner cortex of thyroid cartilage. Glottis: Tumor is limited to the larynx with vocal cord fixation and /or invades the paraglottic space, and/or inner cortex of the thyroid cartilage. Subglottis: Tumor is limited to the larynx with vocal cord fixation

29

Centers

31

Active Trials

—

Cancer Funding

Top Centers for Stage II Laryngeal Cancer AJCC v8(29)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Medical College of Wisconsin Cancer CenterMilwaukee, WI
High-Volume Research Center
72.7
2
The University of Kansas Cancer CenterKansas City, KS
NCI Comprehensive
High-Volume Research Center
72.7
3
UPMC Hillman Cancer CenterPittsburgh, PA
NCI Comprehensive
Active Research Program
50.2
4
UC San Diego Moores Cancer CenterLa Jolla, CA
NCI Comprehensive
Active Research Program
50.2
5
Duke Cancer InstituteDurham, NC
NCI Comprehensive
Active Research Program
50.2
6
The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL
NCI Comprehensive
Active Research Program
50.2
7
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH
NCI Comprehensive
Active Research Program
50.2
8
USC Norris Comprehensive Cancer CenterLos Angeles, CA
NCI Comprehensive
Active Research Program
50.2
9
University of Colorado Cancer CenterAurora, CO
NCI Comprehensive
Active Research Program
50.2
10
Moffitt Cancer CenterTampa, FL
NCI Comprehensive
Active Research Program
50.2
11
Montefiore Einstein Comprehensive Cancer CenterBronx, NY
NCI Comprehensive
Active Research Program
50.2
12
University of Virginia Cancer CenterCharlottesville, VA
NCI Comprehensive
Active Research Program
50.2
13
The University of Arizona Cancer CenterTucson, AZ
NCI Comprehensive
Active Research Program
50.2
14
VCU Massey Comprehensive Cancer CenterRichmond, VA
NCI Comprehensive
Active Research Program
50.2
15
Cleveland Clinic Cancer CenterCleveland, OH
Active Research Program
50.2
16
Holden Comprehensive Cancer CenterIowa City, IA
NCI Comprehensive
Active Research Program
50.2
17
Atrium Health Wake Forest Baptist Comprehensive Cancer CenterWinston-Salem, NC
NCI Comprehensive
Active Research Program
50.2
18
Fred & Pamela Buffett Cancer CenterOmaha, NE
NCI Clinical
Active Research Program
50.2
19
Dartmouth Cancer CenterLebanon, NH
NCI Comprehensive
Active Research Program
50.2
20
University of Illinois Cancer CenterChicago, IL
Active Research Program
50.2
21
University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM
NCI Comprehensive
Active Research Program
50.2
22
UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR
Active Research Program
50.2
23
Boston University Cancer CenterBoston, MA
Active Research Program
50.2
24
Karmanos Cancer InstituteDetroit, MI
NCI Comprehensive
Active Research Program
50.2
25
Cancer Center at IllinoisUrbana, IL
Active Research Program
50.2
26
Penn State Cancer InstituteHershey, PA
Active Research Program
50.2
27
University of Cincinnati Cancer CenterCincinnati, OH
Active Research Program
50.2
28
The University of Vermont Cancer CenterBurlington, VT
Active Research Program
50.2
29
Tampa General Hospital Cancer InstituteTampa, FL
Active Research Program
50.2

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →